← United States · Coverage record
US · SEC FORM 4
APTARGROUP, INC.
ATR · NYSE · CIK 0000896622 · Healthcare · Medical Instruments & Supplies
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
52 Form 4 transaction lines observed in the same window
15 sales · 37 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 12 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2022-11-03 · Trerotola Matthew L..
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- -2.2%
- 3M
- -3.6%
- 6M
- -8.5%
- 12M
- -8.5%
Volatility & liquidity
- Volatility
- 24.4%
- Beta
- —
- Avg daily value
- USD 55.4M
Valuation
- Market cap
- USD 7.7B
- P/E
- 19.5×
Fundamentals
- Profit margin
- 10.4%
- ROE
- 14.7%
- Industry
- Medical Instruments & Supplies
Market data
Price data up to: 2026-10-09 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, P/E, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-27 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 2,089,603
- Previous report
- 1,941,117
- Avg daily volume
- 478,360
- Days to cover
- 4.4
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2022-11-03 | Trerotola Matthew L. | Purchase (P) | Common Stock | 3,170 | USD 94.48 | USD 299,502 | SEC filing ↗ |
Form 4 evidence
95 transaction lines in the latest 365-day window; 589 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Vinczeller Shiela | Sale (S) | Common Stock | 765 | USD 130.37 | USD 99,733 | SEC filing ↗ |
| 2026-09-01 | Touya Gael | Award / grant (A) | Common Stock | 2,637 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-27 | Touya Gael | Sale (S) | Common Stock | 3,740 | USD 133.76 | USD 500,280 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Vinczeller Shiela | Sale (S) | Common Stock | 765 | USD 130.37 | USD 99,733 | SEC filing ↗ |
| 2026-09-01 | Touya Gael | Award / grant (A) | Common Stock | 2,637 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-27 | Touya Gael | Sale (S) | Common Stock | 3,740 | USD 133.76 | USD 500,280 | SEC filing ↗ |
| 2026-08-04 | Prieur Marc | Sale (S) | Common Stock | 3,500 | USD 136.26 | USD 476,913 | SEC filing ↗ |
| 2026-08-03 | Tanda Stephan B. | Sale (S) | Common Stock | 9,838 | USD 136.16 | USD 1,339,542 | SEC filing ↗ |
| 2026-08-03 | Tanda Stephan B. | Option exercise / conversion (M) | Common Stock | 9,838 | USD 74.79 | USD 735,784 | SEC filing ↗ |
| 2026-08-03 | Tlili Hedi | Sale (S) | Common Stock | 8,854 | USD 135.00 | USD 1,195,290 | SEC filing ↗ |
| 2026-07-16 | Xing Julie | Award / grant (A) | Common Stock | 151 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-16 | Wunderlich Ralf K. | Award / grant (A) | Common Stock | 151 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-16 | Trerotola Matthew L. | Award / grant (A) | Common Stock | 151 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-16 | Owens B Craig | Award / grant (A) | Common Stock | 151 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-16 | Matthews Candace S. | Award / grant (A) | Common Stock | 226 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-16 | Marey-Semper Isabel | Award / grant (A) | Common Stock | 151 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-16 | Kampouri Monnas Giovanna | Award / grant (A) | Common Stock | 151 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-16 | Glickman Sarah JS | Award / grant (A) | Common Stock | 151 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-16 | FOTIADES GEORGE L | Award / grant (A) | Common Stock | 151 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-15 | Gandhi Aditya | Award / grant (A) | Common Stock | 2,664 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-09 | Prieur Marc | Sale (S) | Common Stock | 5,000 | USD 115.58 | USD 577,896 | SEC filing ↗ |
| 2026-06-04 | Vinczeller Shiela | Sale (S) | Common Stock | 3,555 | USD 112.62 | USD 400,349 | SEC filing ↗ |
| 2026-05-26 | Gong Xiangwei | Sale (S) | Common Stock | 4,200 | USD 116.13 | USD 487,746 | SEC filing ↗ |
| 2026-05-21 | Tlili Hedi | Tax withholding (F) | Common Stock | 688 | USD 116.50 | USD 80,152 | SEC filing ↗ |
| 2026-05-07 | Hudson Irene Elizabeth | Sale (S) | Common Stock | 1,264 | USD 123.43 | USD 156,011 | SEC filing ↗ |
| 2026-05-07 | Hudson Irene Elizabeth | Option exercise / conversion (M) | Common Stock | 842 | USD 111.38 | USD 93,782 | SEC filing ↗ |
| 2026-05-06 | Xing Julie | Award / grant (A) | Common Stock | 1,326 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-06 | Wunderlich Ralf K. | Award / grant (A) | Common Stock | 1,326 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-06 | Trerotola Matthew L. | Award / grant (A) | Common Stock | 1,326 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-06 | Owens B Craig | Award / grant (A) | Common Stock | 1,326 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-06 | Matthews Candace S. | Award / grant (A) | Common Stock | 1,552 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-06 | Marey-Semper Isabel | Award / grant (A) | Common Stock | 1,326 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-06 | Kampouri Monnas Giovanna | Award / grant (A) | Common Stock | 1,326 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | ATR |
| CIK | 0000896622 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies Yahoo Finance |
| SEC SIC | 3089 Plastics Products, NEC |
| Exchange | NYSE |
Data coverage
| Local Form 4 history | 589 transaction lines from 2020-01-06 to 2026-09-02 1 P purchase lines · 111 S sale lines · 477 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.